Geis N - Search Results

1

One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation.

Pleger ST, Schulz-Schönhagen M, Geis N, Mereles D, Chorianopoulos E, Antaredja M, Lewening M, Katus HA, Bekeredjian R. Pleger ST, et al. Among authors: geis n. Eur J Heart Fail. 2013 Aug;15(8):919-27. doi: 10.1093/eurjhf/hft046. Epub 2013 Mar 19. Eur J Heart Fail. 2013. PMID: 23512096 Free article. Clinical Trial.

2

Ultrasound targeted microbubble destruction for drug and gene delivery.

Mayer CR, Geis NA, Katus HA, Bekeredjian R. Mayer CR, et al. Expert Opin Drug Deliv. 2008 Oct;5(10):1121-38. doi: 10.1517/17425247.5.10.1121. Expert Opin Drug Deliv. 2008. PMID: 18817517 Review.

3

Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability.

Geis NA, Mayer CR, Kroll RD, Hardt SE, Katus HA, Bekeredjian R. Geis NA, et al. Ultrasound Med Biol. 2009 Jul;35(7):1119-26. doi: 10.1016/j.ultrasmedbio.2009.01.008. Epub 2009 May 7. Ultrasound Med Biol. 2009. PMID: 19427103

4

High throughput echocardiography in conscious mice: training and primary screens.

Schoensiegel F, Ivandic B, Geis NA, Schrewe A, Katus HA, Bekeredjian R. Schoensiegel F, et al. Among authors: geis na. Ultraschall Med. 2011 Jan;32 Suppl 1:S124-9. doi: 10.1055/s-0028-1110021. Epub 2010 Feb 24. Ultraschall Med. 2011. PMID: 20183781

5

New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.

Tinkov S, Coester C, Serba S, Geis NA, Katus HA, Winter G, Bekeredjian R. Tinkov S, et al. J Control Release. 2010 Dec 20;148(3):368-72. doi: 10.1016/j.jconrel.2010.09.004. Epub 2010 Sep 22. J Control Release. 2010. PMID: 20868711

6

Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives.

Geis NA, Katus HA, Bekeredjian R. Geis NA, et al. Curr Pharm Des. 2012;18(15):2166-83. doi: 10.2174/138161212800099946. Curr Pharm Des. 2012. PMID: 22352771 Review.

7

Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis.

Chorianopoulos E, Krumsdorf U, Geis N, Pleger ST, Giannitsis E, Katus HA, Bekeredjian R. Chorianopoulos E, et al. Among authors: geis n. Clin Res Cardiol. 2014 Jan;103(1):65-72. doi: 10.1007/s00392-013-0624-8. Epub 2013 Oct 6. Clin Res Cardiol. 2014. PMID: 24096554

8

Procedural results with the self-expanding 31 mm CoreValve aortic bioprosthesis in patients with large annuli.

Murray MI, Geis N, Pleger ST, Katus HA, Bekeredjian R, Chorianopoulos E. Murray MI, et al. Among authors: geis n. J Interv Cardiol. 2014 Apr;27(2):191-8. doi: 10.1111/joic.12090. Epub 2014 Jan 16. J Interv Cardiol. 2014. PMID: 24433399 Free article.

9

Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair.

Geis NA, Pleger ST, Chorianopoulos E, Müller OJ, Katus HA, Bekeredjian R. Geis NA, et al. EuroIntervention. 2015 Mar;10(11):1346-53. doi: 10.4244/EIJV10I11A231. EuroIntervention. 2015. PMID: 24694560 Free article. Clinical Trial.

10

Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters.

Geis NA, Chorianopoulos E, Kallenbach K, André F, Pleger ST, Karck M, Katus HA, Bekeredjian R. Geis NA, et al. Clin Res Cardiol. 2014 Oct;103(10):775-80. doi: 10.1007/s00392-014-0713-3. Epub 2014 Apr 21. Clin Res Cardiol. 2014. PMID: 24748131 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters